Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939

Castration-resistant prostate cancer (CRPC) is a common form of prostate cancer in which docetaxel-based chemotherapy is used as the first line. The present study is devoted to the analysis of transcriptome profiles of tumor cells in the development of resistance to docetaxel as well as to the asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Pudova, Elena, Kobelyatskaya, Anastasiya, Katunina, Irina, Snezhkina, Anastasiya, Nyushko, Kirill, Fedorova, Maria, Pavlov, Vladislav, Bulavkina, Elizaveta, Dalina, Alexandra, Tkachev, Sergey, Alekseev, Boris, Krasnov, George, Volodin, Vsevolod, Kudryavtseva, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658696/
https://www.ncbi.nlm.nih.gov/pubmed/36361635
http://dx.doi.org/10.3390/ijms232112837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658696/
https://www.ncbi.nlm.nih.gov/pubmed/36361635
http://dx.doi.org/10.3390/ijms232112837

Ejemplares similares